BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3977937)

  • 1. Ammonium inhibition of fatty acid oxidation in rat liver mitochondria. A possible cause of fatty liver in Reye's syndrome and urea cycle defects.
    Maddaiah VT
    Biochem Biophys Res Commun; 1985 Mar; 127(2):565-70. PubMed ID: 3977937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ammonium chloride inhibits pyruvate oxidation in rat liver mitochondria: a possible cause of fatty liver in Reye's syndrome and urea cycle defects.
    Maddaiah VT; Kumbar U
    Clin Sci (Lond); 1994 Nov; 87(5):499-503. PubMed ID: 7874836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mitochondrial fatty acid oxidation in pentenoic acid-induced fatty liver. A possible model for Reye's syndrome.
    Thayer WS
    Biochem Pharmacol; 1984 Apr; 33(8):1187-94. PubMed ID: 6712730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mitochondrial functions by margosa oil: possible implications in the pathogenesis of Reye's syndrome.
    Koga Y; Yoshida I; Kimura A; Yoshino M; Yamashita F; Sinniah D
    Pediatr Res; 1987 Aug; 22(2):184-7. PubMed ID: 3658544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibitory effect of long-chain acyl-CoA esters on succinate and glutamate transport into rat liver mitochondria and its possible implications for long-chain fatty acid oxidation defects.
    Ventura FV; Ruiter J; Ijlst L; de Almeida IT; Wanders RJ
    Mol Genet Metab; 2005 Nov; 86(3):344-52. PubMed ID: 16176879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome.
    Deschamps D; Fisch C; Fromenty B; Berson A; Degott C; Pessayre D
    J Pharmacol Exp Ther; 1991 Nov; 259(2):894-904. PubMed ID: 1941634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of peroxidized polyunsaturated fatty acids on mitochondrial function and structure: pathogenetic implications for Reye's syndrome.
    Brown RE; Bhuvaneswaran C; Brewster M
    Ann Clin Lab Sci; 1988; 18(4):337-43. PubMed ID: 2900617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some aspects of fatty acid oxidation in isolated fat-cell mitochondria from rat.
    Harper RD; Saggerson ED
    Biochem J; 1975 Dec; 152(3):485-94. PubMed ID: 1227502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of salicylic acid on mitochondrial-peroxisomal fatty acid catabolism.
    Yoshida Y; Fujii M; Brown FR; Singh I
    Pediatr Res; 1988 Mar; 23(3):338-41. PubMed ID: 3353181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of beta-oxidation by 3-mercaptopropionic acid produces features of Reye's syndrome in perfused rat liver.
    Yamamoto M; Nakamura Y
    Gastroenterology; 1994 Aug; 107(2):517-24. PubMed ID: 8039627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reye's syndrome: the effect of patient serum on mitochondrial respiration in vitro.
    Asimakis GK; Aprille JR
    Biochem Biophys Res Commun; 1977 Dec; 79(4):1122-9. PubMed ID: 603647
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of ammonium chloride, salicylate, and carnitine on palmitic acid oxidation in rat liver slices.
    Maddaiah VT; Miller PS
    Pediatr Res; 1989 Feb; 25(2):119-23. PubMed ID: 2919125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.
    Osterloh J; Cunningham W; Dixon A; Combest D
    Med Toxicol Adverse Drug Exp; 1989; 4(4):272-94. PubMed ID: 2671597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of hepatic mitochondrial urea-cycle enzyme activities and hepatic ultrastructure in acute fatty liver of pregnancy.
    Weber FL; Snodgrass PJ; Powell DE; Rao P; Huffman SL; Brady PG
    J Lab Clin Med; 1979 Jul; 94(1):27-41. PubMed ID: 469376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reye's syndrome: patient serum alters mitochondrial function and morphology in vitro.
    Aprille JR
    Science; 1977 Aug; 197(4306):908-10. PubMed ID: 887930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic disorders mimicking Reye's syndrome.
    Chang PF; Huang SF; Hwu WL; Hou JW; Ni YH; Chang MH
    J Formos Med Assoc; 2000 Apr; 99(4):295-9. PubMed ID: 10870312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 2-mercaptoacetate in isolated liver mitochondria in vitro. Competitive inhibition of 3-hydroxybutyrate dehydrogenase and depression of the beta-oxidation pathway.
    Bauché F; Sabourault D; Giudicelli Y; Nordmann J; Nordmann R
    Biochem J; 1982 Jul; 206(1):53-9. PubMed ID: 7126196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 22 kDa polyanion inhibits carnitine-dependent fatty acid oxidation in rat liver mitochondria.
    Turkaly P; Kerner J; Hoppel C
    FEBS Lett; 1999 Oct; 460(2):241-5. PubMed ID: 10544243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reye's syndrome: salicylates and mitochondrial functions.
    Martens ME; Lee CP
    Biochem Pharmacol; 1984 Sep; 33(18):2869-76. PubMed ID: 6477646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium benzoate inhibits fatty acid oxidation in rat liver: effect on ammonia levels.
    Kalbag SS; Palekar AG
    Biochem Med Metab Biol; 1988 Oct; 40(2):133-42. PubMed ID: 3190922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.